2’-fucosyllactose Supplementation Improves Gut-Brain Signaling and Diet-Induced Obese Phenotype and Changes the Gut Microbiota in High Fat-Fed Mice
Obesity is characterized by fat accumulation, chronic inflammation and impaired satiety signaling, which may be due in part to gut microbial dysbiosis. Manipulations of the gut microbiota and its metabolites are attractive targets for obesity treatment. The predominant oligosaccharide found in human...
Main Authors: | Sunhye Lee, Michael Goodson, Wendie Vang, Karen Kalanetra, Daniela Barile, Helen Raybould |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-04-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/12/4/1003 |
Similar Items
-
The Protective Effects of 2’-Fucosyllactose against <i>E. Coli</i> O157 Infection Are Mediated by the Regulation of Gut Microbiota and the Inhibition of Pathogen Adhesion
by: Yuanyifei Wang, et al.
Published: (2020-05-01) -
Impact of 2′-Fucosyllactose on Gut Microbiota Composition in Adults with Chronic Gastrointestinal Conditions: Batch Culture Fermentation Model and Pilot Clinical Trial Findings
by: Jennifer Joan Ryan, et al.
Published: (2021-03-01) -
Metabolic Responses to Butyrate Supplementation in LF- and HF-Fed Mice Are Cohort-Dependent and Associated with Changes in Composition and Function of the Gut Microbiota
by: Sunhye Lee, et al.
Published: (2020-11-01) -
Effects of the Lipid Metabolites and the Gut Microbiota in ApoE−/− Mice on Atherosclerosis Co-Depression From the Microbiota-Gut-Brain Axis
by: He, W.-F, et al.
Published: (2022) -
The Gut Microbiota-brain Signaling: Behavioral Abnormalities of The Gut Microbiota Underlie Alzheimer’s Disease Development and Progression. Dictatorship or Bidirectional Relationship?
by: Menizibeya O Welcome
Published: (2018-10-01)